BNCM | DELEX
PRESS RELEASE
1. BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth
Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) are excited to announce their Strategic Merger to further drive their expansion and growth plans.
Driven by a shared objective, DELEX and BNCM formed a strategic alliance to elevate the pharmaceutical industry in the Philippines to align with its status as one of the most attractive pharmaceutical markets in the Asia-Pacific region. The proposed merger further supports the aim of DELEX to meet the gaps in critical care by providing alternative drugs for Intensive Care Unit (ICU) patients.
2. BNCM and DELEX Healthcare Group, Inc. Announce their Expansion Plans to Solidify Market Presence
Bounce Mobile Systems Inc. (BNCM) and Delex Healthcare Group, Inc. (DELEX), a profitable and fast-growing healthcare and pharmaceutical company, today announce their expansion plans designed to solidify the market position and drive the future growth of DELEX.
With DELEXs successful union and strategic merger alliance with Bounce Mobile Systems Inc. (BNCM), the shared objective of fostering a better market presence, while continuing to meet the gaps of critical care patients with accessible medical treatments, presents an enticing opportunity for interested investors, shareholders, and partners seeking opportunities in the growing Southeast Asia healthcare industry.
3. BNCM and DELEX Unveil Post-Merger Management Plans
Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) are pleased to announce their management plans following the merger announcement on July 2, 2024.
This strategic merger represents a significant milestone for both companies, aimed at combining their strengths to enhance operational efficiency and market reach which is set to drive innovation and growth in the healthcare industry. With a clear roadmap for regulatory compliance, asset transfer, and integrated management, DELEX is poised to deliver greater value to its stakeholders.
4. BNCM Announces Strategic Partnership between Delex and Verathon
Delex Pharma has announced a new distributorship agreement with Verathon to market its advanced and. Innovative video laryngoscopes GLIDESCOPE GO, including the GlideScope Titanium Reusable and GlideScope Spectrum Single-use models.
5. BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth
3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects Delex Pharma’s commitment to addressing critical healthcare needs in the Philippines, particularly in the fields of critical care, oncology, anesthesia, and medical devices.
6. BNCM Announces the Expansion of DELEX PHARMA’s Medical Device Business
9th September 2024 BNCM announces today the expansion of DELEX PHARMAs medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the companys total revenue, reinforcing DELEXs rapid growth in the healthcare sector.
7. BNCM Announces that DELEX ICU FORUMS has reached a Global Audience of almost 200,000 Healthcare Professionals
September 16th, 2024; BNCM is excited to announce that the ICU (Intensive Care Unit) Forums conducted by DELEX have reached a Global Audience of almost 200,000 Healthcare Professionals.
8. BNCM Announces DELEX Acquisition of JMN Brothers Pharma
September 2024 DELEX Pharma International, Inc. has acquired JMN Brothers Pharma Limited, Inc. (JMN Pharma) in 2022. JMN Pharma was established in 2018 and known for its expertise in Women’s Health and Beauty, along with its ethical business in hospital products. The company is led by experienced executives from multinational pharmaceutical organizations. This strategic acquisition is projected to account for 20% of DELEX Pharma’s total corporate revenue, further strengthening its position in the over-the-counter (OTC) healthcare market.
9. BNCM: DELEX Critical Care Products Approved by the Philippine FDA
As DELEX Pharma engages in the hospital sector, it upholds the highest ethical standards for patient safety by providing a diverse range of critical care products approved by the Philippine Food and Drug Administration (FDA). This strict adherence to regulatory requirements not only ensures patient well-being but also strengthens the trust and credibility the company has built with hospitals across the country, contributing to steady product sales and revenue growth.
10. TIMELINE: BNCM COMPLETES MERGER WITH DELEX HEALTHCARE
October 2024. Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) have successfully completed their merger and unveiled their post-merger and management plans.
DELEX, a Delaware-registered company, serves as the holding company for DLX Holdings, Inc. (DLX). DLX, based in the Philippines, holds a 60% controlling interest in DELEX Pharma International, Inc., one of the fastest players in the pharmaceutical and medical device industries in the country.
11. BNCM: DELEX to Revolutionize ICU with its FDA Approved Products
DELEXs unwavering dedication to addressing the crucial needs of critical care within the healthcare landscape has intensified further and is set to propel DELEX’s growth trajectory and expand its reach ensuring enhanced accessibility to essential healthcare solutions across the country.
12. BNCM: DELEX ANNOUNCE EXPANSION PLANS FOR ITS PHARMACY
The Philippines, with its population exceeding 114 million across 7,641 islands, presents a strong opportunity for growth in the pharmacy retail industry. The countrys expanding population, rising economy, and increasing incomes are driving higher demand globally for healthcare products and services.
13. BNCM Announces its Q3 and 9-Month Growth Results for 2024
BNCM has issued its Quarterly Report for the period ending September 30, 2024.
On July 2, 2024, Bounce Mobile Systems, Inc. (BNCM) signed an Asset Purchase Agreement with Delex Healthcare Group, Inc. (DELEX), a Delaware-registered corporation that owns DLX Holdings, Inc., a Philippine-based company. This strategic acquisition spotlights BNCM’s commitment to expanding its portfolio and operational footprint in the healthcare sector.
14. BNCM: DELEX PHARMA Bolsters Market Reach Through 6 Major Conventions in November 2024
Delex Pharma International, Inc. (Delex Pharma) strengthened its market presence in 2024 by complementing its digital initiatives, such as the ICU Forum, with participation in six major on-ground conventions, the majority of which took place in November 2024. Additionally, we have conducted hybrid webinars and events with forty-four (44) partner medical societies and hospital departments. These events target key healthcare professionals across multiple specialties, enhancing brand visibility and engagement.
15. DELEX Announces its Partnership with Masimo to Revolutionize Critical Care in the Philippines
DELEX Pharma International Inc. (DELEX Pharma) proudly announces its groundbreaking partnership with Masimo, a global leader in innovative noninvasive monitoring technologies, and a trusted name of intensive care unit and medical device solutions in the Philippines.